Compounded formulations of GLP-1s are not reviewed by the FDA for safety, efficacy, or quality
instead, work with your provider to optimize your individual protocol and prevent appetite rebound
However, under caloric restriction, these changes can paradoxically reduce anabolic signaling, impairing protein synthesis
Disease categories were described using validated definitions 58,59,60
Currently, neither Saxenda nor Wegovy is subsidized by the Pharmaceutical Benefits Scheme (PBS) specifically for obesity treatment, though Ozempic (the 1mg semaglutide version) is available on the PBS for diabetes management
Can oral semaglutide be used in combination with other medications